Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.5 Billion CNY | 5.21% |
| 2022 | 1.43 Billion CNY | 7.71% |
| 2021 | 1.33 Billion CNY | 18.61% |
| 2020 | 1.12 Billion CNY | -16.65% |
| 2019 | 1.34 Billion CNY | 12.92% |
| 2018 | 1.19 Billion CNY | 75.56% |
| 2017 | 679.38 Million CNY | 46.35% |
| 2016 | 464.2 Million CNY | 129.35% |
| 2015 | 202.39 Million CNY | 128.47% |
| 2014 | 88.58 Million CNY | 24.51% |
| 2013 | 71.14 Million CNY | -26.16% |
| 2012 | 96.35 Million CNY | 147.01% |
| 2011 | 39 Million CNY | 56.83% |
| 2010 | 24.87 Million CNY | 16.54% |
| 2009 | 21.34 Million CNY | 56.88% |
| 2008 | 13.6 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.6 Billion CNY | 2.63% |
| 2024 Q3 | 1.79 Billion CNY | 12.36% |
| 2024 Q1 | 1.55 Billion CNY | 3.32% |
| 2023 FY | 1.5 Billion CNY | 5.21% |
| 2023 Q4 | 1.5 Billion CNY | 0.35% |
| 2023 Q1 | 1.56 Billion CNY | 8.83% |
| 2023 Q3 | 1.5 Billion CNY | -0.3% |
| 2023 Q2 | 1.5 Billion CNY | -3.37% |
| 2022 Q3 | 1.7 Billion CNY | 1.37% |
| 2022 Q1 | 1.53 Billion CNY | 14.96% |
| 2022 FY | 1.43 Billion CNY | 7.71% |
| 2022 Q4 | 1.43 Billion CNY | -15.72% |
| 2022 Q2 | 1.67 Billion CNY | 9.67% |
| 2021 Q3 | 1.32 Billion CNY | 11.37% |
| 2021 Q1 | 1.26 Billion CNY | 12.9% |
| 2021 FY | 1.33 Billion CNY | 18.61% |
| 2021 Q4 | 1.33 Billion CNY | 0.59% |
| 2021 Q2 | 1.18 Billion CNY | -6.22% |
| 2020 Q2 | 1.33 Billion CNY | 4.43% |
| 2020 Q1 | 1.28 Billion CNY | -4.73% |
| 2020 FY | 1.12 Billion CNY | -16.65% |
| 2020 Q3 | 1.37 Billion CNY | 2.45% |
| 2020 Q4 | 1.12 Billion CNY | -18.22% |
| 2019 Q1 | 948.96 Million CNY | -20.44% |
| 2019 FY | 1.34 Billion CNY | 12.92% |
| 2019 Q2 | 1.14 Billion CNY | 20.57% |
| 2019 Q3 | 1.34 Billion CNY | 17.75% |
| 2019 Q4 | 1.34 Billion CNY | -0.03% |
| 2018 Q3 | 1.09 Billion CNY | 7.31% |
| 2018 Q2 | 1.02 Billion CNY | 51.39% |
| 2018 Q1 | 674.59 Million CNY | -0.71% |
| 2018 FY | 1.19 Billion CNY | 75.56% |
| 2018 Q4 | 1.19 Billion CNY | 8.83% |
| 2017 FY | 679.38 Million CNY | 46.35% |
| 2017 Q2 | 580.44 Million CNY | 29.53% |
| 2017 Q3 | 617.21 Million CNY | 6.33% |
| 2017 Q1 | 448.11 Million CNY | -3.47% |
| 2017 Q4 | 679.38 Million CNY | 10.07% |
| 2016 Q3 | 371.17 Million CNY | 14.09% |
| 2016 Q1 | 252.12 Million CNY | 24.57% |
| 2016 FY | 464.2 Million CNY | 129.35% |
| 2016 Q4 | 464.2 Million CNY | 25.06% |
| 2016 Q2 | 325.34 Million CNY | 29.04% |
| 2015 Q2 | 110.11 Million CNY | 2.99% |
| 2015 Q1 | 106.91 Million CNY | 20.69% |
| 2015 Q3 | 186.29 Million CNY | 69.19% |
| 2015 Q4 | 202.39 Million CNY | 8.64% |
| 2015 FY | 202.39 Million CNY | 128.47% |
| 2014 FY | 88.58 Million CNY | 24.51% |
| 2014 Q4 | 88.58 Million CNY | 16.48% |
| 2014 Q1 | 71.63 Million CNY | 0.68% |
| 2014 Q3 | 76.05 Million CNY | 3.28% |
| 2014 Q2 | 73.64 Million CNY | 2.8% |
| 2013 Q4 | 71.14 Million CNY | -9.0% |
| 2013 Q2 | 91.74 Million CNY | 13.2% |
| 2013 Q1 | 81.05 Million CNY | -15.88% |
| 2013 FY | 71.14 Million CNY | -26.16% |
| 2013 Q3 | 78.18 Million CNY | -14.79% |
| 2012 Q2 | 80.7 Million CNY | 84.01% |
| 2012 Q1 | 43.86 Million CNY | 12.44% |
| 2012 Q3 | 87.22 Million CNY | 8.08% |
| 2012 FY | 96.35 Million CNY | 147.01% |
| 2012 Q4 | 96.35 Million CNY | 10.46% |
| 2011 Q3 | 40.43 Million CNY | 13.08% |
| 2011 Q4 | 39 Million CNY | -3.52% |
| 2011 Q2 | 35.75 Million CNY | 20.71% |
| 2011 Q1 | 29.62 Million CNY | 19.1% |
| 2011 FY | 39 Million CNY | 56.83% |
| 2010 Q4 | 24.87 Million CNY | 0.0% |
| 2010 FY | 24.87 Million CNY | 16.54% |
| 2009 FY | 21.34 Million CNY | 56.88% |
| 2008 FY | 13.6 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -6349.142% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | -163.372% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -556.794% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | -482.583% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | -66.277% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | -329.41% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -1415.649% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | -150.58% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -5142.564% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | -310.364% |